Literature DB >> 22492855

Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus.

David R Cameron1, Doyle V Ward, Xenia Kostoulias, Benjamin P Howden, Robert C Moellering, George M Eliopoulos, Anton Y Peleg.   

Abstract

The genetic mechanisms that contribute to reduced susceptibility to vancomycin in Staphylococcus aureus are complex and heterogeneous. In addition, debate is emerging as to the true effect of reduced susceptibility to vancomycin on staphylococcal virulence. To investigate this, comparative genomics was performed on a collection of vancomycin-exposed isogenic S. aureus pairs (14 strains in total). Previously described mutations were observed in genes such as vraG, agrA, yvqF, and rpoB; however, a new mechanism was identified involving a serine/threonine phosphatase, Stp1. After constructing an stp1 deletion mutant, we showed that stp1 is important in vancomycin susceptibility and cell wall biosynthesis. Gene expression studies showed that stp1 also regulates virulence genes, including a hemolysin, superantigen-like protein, and phenol-soluble modulin, and that the deletion mutant is attenuated in virulence in vivo. Stp1 provides a new link between vancomycin susceptibility and virulence in S. aureus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492855      PMCID: PMC3415852          DOI: 10.1093/infdis/jis252

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus.

Authors:  K Sieradzki; A Tomasz
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mark C Enright; D Ashley Robinson; Gaynor Randle; Edward J Feil; Hajo Grundmann; Brian G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.

Authors:  Mitsutaka Shoji; Longzhu Cui; Risa Iizuka; Akira Komoto; Hui-min Neoh; Yukiko Watanabe; Tomomi Hishinuma; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

4.  A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

Authors:  M Wootton; R A Howe; R Hillman; T R Walsh; P M Bennett; A P MacGowan
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

5.  Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

Authors:  L Cui; H Murakami; K Kuwahara-Arai; H Hanaki; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

6.  Inactivation of a novel three-cistronic operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus.

Authors:  M Brandenberger; M Tschierske; P Giachino; A Wada; B Berger-Bächi
Journal:  Biochim Biophys Acta       Date:  2000-10-18

7.  Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.

Authors:  George Sakoulas; George M Eliopoulos; Robert C Moellering; Christine Wennersten; Lata Venkataraman; Richard P Novick; Howard S Gold
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

8.  Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation.

Authors:  B T Bateman; N P Donegan; T M Jarry; M Palma; A L Cheung
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.

Authors:  L Vincent Collins; Sascha A Kristian; Christopher Weidenmaier; Marion Faigle; Kok P M Van Kessel; Jos A G Van Strijp; Friedrich Götz; Birgid Neumeister; Andreas Peschel
Journal:  J Infect Dis       Date:  2002-07-03       Impact factor: 5.226

10.  BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data.

Authors:  Lao H Saal; Carl Troein; Johan Vallon-Christersson; Sofia Gruvberger; Ake Borg; Carsten Peterson
Journal:  Genome Biol       Date:  2002-07-15       Impact factor: 13.583

View more
  47 in total

1.  Differential gene expression in Staphylococcus aureus exposed to Orange II and Sudan III azo dyes.

Authors:  Hongmiao Pan; Joshua Xu; Oh-Gew Kweon; Wen Zou; Jinhui Feng; Gui-Xin He; Carl E Cerniglia; Huizhong Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2015-02-27       Impact factor: 3.346

2.  In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?

Authors:  Sebastiaan J van Hal; Jason A Steen; Björn A Espedido; Sean M Grimmond; Matthew A Cooper; Matthew T G Holden; Stephen D Bentley; Iain B Gosbell; Slade O Jensen
Journal:  J Antimicrob Chemother       Date:  2013-09-18       Impact factor: 5.790

Review 3.  Do Shoot the Messenger: PASTA Kinases as Virulence Determinants and Antibiotic Targets.

Authors:  Daniel A Pensinger; Adam J Schaenzer; John-Demian Sauer
Journal:  Trends Microbiol       Date:  2017-07-19       Impact factor: 17.079

Review 4.  Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.

Authors:  Edward Geisinger; Ralph R Isberg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus.

Authors:  Wei Gao; David R Cameron; John K Davies; Xenia Kostoulias; Justin Stepnell; Kellie L Tuck; Michael R Yeaman; Anton Y Peleg; Timothy P Stinear; Benjamin P Howden
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

Review 6.  Regulation of virulence and antibiotic resistance in Gram-positive microbes in response to cell wall-active antibiotics.

Authors:  Jessica J Evans; Devin D Bolz
Journal:  Curr Opin Infect Dis       Date:  2019-06       Impact factor: 4.915

Review 7.  Resisting resistance: gearing up for war.

Authors:  Aurijit Sarkar; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2019-08-07       Impact factor: 3.597

8.  VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.

Authors:  Yuanyuan Dai; Wenjiao Chang; Changcheng Zhao; Jing Peng; Liangfei Xu; Huaiwei Lu; Shusheng Zhou; Xiaoling Ma
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

9.  Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.

Authors:  Celine Vidaillac; Susana Gardete; Ryan Tewhey; George Sakoulas; Glenn W Kaatz; Warren E Rose; Alexander Tomasz; Michael J Rybak
Journal:  J Infect Dis       Date:  2013-03-28       Impact factor: 5.226

10.  Genome sequence-based discriminator for vancomycin-intermediate Staphylococcus aureus.

Authors:  Lavanya Rishishwar; Robert A Petit; Colleen S Kraft; I King Jordan
Journal:  J Bacteriol       Date:  2013-12-20       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.